retatrutide twitter Vial of unapproved peptide had double the strength indicated on label Retatrutide and Semaglutide Together: Safety

Research into GLP-1 patches specifically is limited

158 DDIs with Oral Contraceptives Some GLP-1 RAs and a dual GLP-1/GIP RA altered the exposure of oral contraceptives, implying the potential for clinically significant DDIs (Table 4)

Galidesivir (BCX4430), an adenosine nucleoside derivative with wide-ranging action towards RNA viruses, is now being tested in COVID-19 (ClinicalTrials.gov Identifier: NCT03891420) that was effective towards flaviviruses like Zika

By incorporating estrous monitoring into current pre-clinical biomedical research, experimenters can assess differential effects of drugs and doses across estrous phases, which will be critical for understanding how drugs interact with endogenous fluctuations in hormonal state 72

Theres no doubt that GLP-1s are transforming obesity medicine

The compounded GLP-1 era is ending